Thursday, May 5th, 2016

According to researcher, the Myocardial Infarction Therapeutics Market is estimated at $XX million in 2015 and is projected to reach $XX million by 2022 growing at a CAGR of XX% from 2015 to 2022. Growing research application, rising demand in increasing incidence of coronary artery disease and changes in lifestyle are some of the key factors driving the market growth. Increasing number of smokers, increasing incidence of obesity and blood pressures, lack of exercise are some of the factors favouring the market growth. However, saturation in R&D would be the major restraint hampering the market.

Complete report details @


Analgesics and antiplatelet agents segments are expected to hold more share in this market as these agents are used for initial treatment of an acute myocardial infarction. North America is the fastest growing market in global myocardial infarction therapeutic market due to rise in aging population and prevalence of co-morbidities.

Some of the key players in the market include Anthera Pharmaceuticals, AstraZeneca, Apotex Inc., Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Capricor Inc., Daiichi Sankyo Company Limited, GlaxoSmithKline Plc, Johnson & Johnson, Merck and Co. Inc., Mylan N.V., Novartis N.V., Par Pharmaceutical Companies, Inc., Pfizer Inc., Portola Pharmaceuticals Inc., Sandoz, Sanofi and The Medicines Company.

Request a sample report @


Products Covered: 
• Analgesics 
• Antiplatelet agents 
• Vasodilators 
• Thrombolytics and anti-thrombotic agents 
• Glycoprotein IIb/IIIa inhibitors 
• Β adrenergic blockers 
• Angiotensin receptor antagonists 
• Angiotensin converting enzyme inhibitors 
• Antithrombotic agents

Distribution Channel Covered: 
• Hospitals 
• Hospital Pharmacies 
• Drug Stores 
• Online drug stores

What our report offers: 
- Market share assessments for the regional and country level segments 
- Market share analysis of the top industry players 
- Strategic recommendations for the new entrants 
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets 
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) 
- Strategic recommendations in key business segments based on the market estimations 
- Competitive landscaping mapping the key common trends 
- Company profiling with detailed strategies, financials, and recent developments 
- Supply chain trends mapping the latest technological advancements

Make an enquiry before buying this Report @


Table of content

1 Executive Summary 

2 Preface 
2.1 Abstract 
2.2 Stake Holders 
2.3 Research Scope 
2.4 Research Methodology 
2.4.1 Data Mining 
2.4.2 Data Analysis 
2.4.3 Data Validation 
2.4.4 Research Approach 
2.5 Research Sources 
2.5.1 Primary Research Sources 
2.5.2 Secondary Research Sources 
2.5.3 Assumptions 

3 Market Trend Analysis 
3.1 Introduction 
3.2 Drivers 
3.3 Restraints 
3.4 Opportunities 
3.5 Threats 
3.6 Product Analysis 
3.7 Emerging Markets 

4 Porters Five Force Analysis 
4.1 Bargaining power of suppliers 
4.2 Bargaining power of buyers 
4.3 Threat of substitutes 
4.4 Threat of new entrants 
4.5 Competitive rivalry 

5 Global Myocardial Infarction Therapeutics Market, By Product Type 
5.1 Introduction 
5.2 Analgesics 
5.3 Antiplatelet agents 
5.4 Vasodilators 
5.5 Thrombolytics and anti-thrombotic agents 
5.6 Glycoprotein IIb/IIIa inhibitors 
5.7 Β adrenergic blockers 
5.8 Angiotensin receptor antagonists 
5.9 Angiotensin converting enzyme inhibitors 
5.10 Antithrombotic agents 

6 Global Myocardial Infarction Therapeutics Market, By Distribution channel 
6.1 Introduction 
6.2 Hospitals 
6.3 Hospital Pharmacies 
6.4 Drug Stores 
6.5 Online drug stores 

7 Global Myocardial Infarction Therapeutics Market, By Geography 
7.1 North America 
7.1.1 US 
7.1.2 Canada 
7.1.3 Mexico 
7.2 Europe 
7.2.1 Germany 
7.2.2 France 
7.2.3 Italy 
7.2.4 UK 
7.2.5 Spain 
7.2.6 Rest of Europe 
7.3 Asia Pacific 
7.3.1 Japan 
7.3.2 China 
7.3.3 India 
7.3.4 Australia 
7.3.5 New Zealand 
7.3.6 Rest of Asia Pacific 
7.4 Rest of the World 
7.4.1 Middle East 
7.4.2 Brazil 
7.4.3 Argentina 
7.4.4 South Africa 
7.4.5 Egypt 

8 Key Developments 
8.1 Agreements, Partnerships, Collaborations and Joint Ventures 
8.2 Acquisitions & Mergers 
8.3 New Product Launch 
8.4 Expansions 
8.5 Other Key Strategies 

9 Company Profiling 
9.1 Anthera Pharmaceuticals 
9.2 AstraZeneca, Apotex Inc. 
9.3 Bayer AG 
9.4 Boehringer Ingelheim GmbH 
9.5 Bristol-Myers Squibb Company 
9.6 Capricor Inc. 
9.7 Daiichi Sankyo Company Limited 
9.8 GlaxoSmithKline Plc 
9.9 Johnson & Johnson 
9.10 Merck and Co. Inc. 
9.11 Mylan N.V. 
9.12 Novartis N.V. 
9.13 Par Pharmaceutical Companies, Inc. 
9.14 Pfizer Inc. 
9.15 Portola Pharmaceuticals Inc. 
9.16 Sandoz 
9.17 Sanofi 
9.18 The Medicines Company 

Buy this report @


Contact US:


Partner Relations & Marketing Manager

[email protected]

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

File Library

Contact Profile


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Our Market Research Reports and Consulting Services 

Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations.

Hundreds of large and small organizations across virtually every industry sector worldwide are currently reaping rich dividends from the sharp insights provided by market research reports sourced through Wise Guy Reports. 

Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment. The handpicked collection of market research reports on Wise Guy Reports is centred on this proven principle.

Norah Trent
P: +44 208 133 9349
M: +1 646 845 9349


Myocardial Infarction Therapeutics market trend, Myocardial Infarction Therapeutics market segmentation, Myocardial Infarction Therapeutics market analysis, Myocardial Infarction Therapeutics market parameters, Myocardial Infarction Therapeutics indu




More Formats

View QR Code